Published in J Infect Dis on July 01, 1982
Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus. Antimicrob Agents Chemother (1987) 1.30
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. J Clin Pathol (1988) 0.86
Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol (1992) 0.85
Alpha-interferon administration in cytomegalovirus retinitis. Antimicrob Agents Chemother (1984) 0.80
Neurotoxic effects during vidarabine therapy for herpes zoster. Can Med Assoc J (1985) 0.78
Inhibition of human cytomegalovirus by combined acyclovir and vidarabine. Antimicrob Agents Chemother (1985) 0.77
Vidarabine-associated encephalopathy and myoclonus. Antimicrob Agents Chemother (1986) 0.75
Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection. Antimicrob Agents Chemother (1989) 0.75
Prevention and treatment of cytomegalovirus infections with interferons and immune globulins. Infection (1985) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature (1980) 3.78
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Iron Metabolism. Heme Synthesis in Vitro by Immature Erythrocytes. Science (1949) 3.14
Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet (1986) 3.14
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med (1990) 2.66
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med (1992) 2.33
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med (1985) 2.28
Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24
Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med (1985) 2.23
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis (1995) 2.20
Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology (1984) 2.19
Diagnosis of cytomegaloviral pneumonia by in situ hybridization. J Infect Dis (1984) 2.18
Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA (1994) 2.14
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet (1972) 2.13
Production of interferon by human leukocytes in vitro. Ann Med Exp Biol Fenn (1966) 2.13
Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol (1997) 2.11
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10
Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med (1984) 2.05
Further studies on the production of interferon by human leukocyte in vitro. Ann Med Exp Biol Fenn (1967) 2.04
Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature (1987) 2.04
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med (1993) 2.01
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med (1986) 1.99
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med (1994) 1.97
Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med (1991) 1.96
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol (1990) 1.91
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89
Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology (1980) 1.88
Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85
Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med (1993) 1.84
Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood (1992) 1.83
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Technique for human marrow grafting. Blood (1970) 1.83
Differential expression of human interferon genes. Nucleic Acids Res (1984) 1.82
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79
Partial purification of human leukocyte interferon on a large scale. Methods Enzymol (1981) 1.79
Infection with varicella-zoster virus after marrow transplantation. J Infect Dis (1985) 1.77
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77
Allogeneic marrow grafting for treatment of aplastic anemia. Blood (1974) 1.76
Raising antibodies to human leukocyte interferon. Acta Pathol Microbiol Scand B (1975) 1.76
Bone marrow grafts and tolerance. Nature (1986) 1.74
Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med (1988) 1.72
Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol (1988) 1.72
Large-scale production of human leukocyte interferon containing 10(8) units per ml. J Gen Virol (1978) 1.72
Marrow transplantation for thalassaemia. Lancet (1982) 1.71
Secretion of interferon by Bacillus subtilis. Gene (1983) 1.70
An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis (1992) 1.69
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol (1975) 1.67
Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med (1982) 1.67
Giardia lamblia infection in homosexual men. Br J Vener Dis (1977) 1.65
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood (1987) 1.63
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Human leukocyte interferon: production, purification, stability, and animal experiments. In Vitro Monogr (1974) 1.62
Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J Infect Dis (1991) 1.62
Shigellosis at sea: an outbreak aboard a passenger cruise ship. Am J Epidemiol (1975) 1.60
Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet (1984) 1.60
Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation (1974) 1.58
The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol (1977) 1.58
Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. J Gen Virol (1975) 1.57
Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol (1999) 1.57
Hemophilia: role of organ homografts. Science (1969) 1.56
Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med (1981) 1.56